Life Sciences Tools and Services
Company Overview of GnuBIO, Inc.
GnuBIO, Inc. develops DNA sequencing systems for clinical and research applications. The company offers beta system instruments and single consumable cartridges for the interrogation of single genes, gene panels, or whole genomes. It provides systems for DNA sequencing, including target selection/enrichment, DNA amplification, DNA sequencing, and analysis. The company was founded in 2009 and is based in Cambridge, Massachusetts. As of April 10, 2014, GnuBIO, Inc. operates as a subsidiary of Bio-Rad Laboratories, Inc.
64 Sidney Street
Cambridge, MA 02139
Founded in 2009
Key Executives for GnuBIO, Inc.
Executive Vice President of Product Development
Vice President of Informatics
Compensation as of Fiscal Year 2014.
GnuBIO, Inc. Key Developments
GnuBIO, Inc. Presents at Cowen and Company, LLC's 33rd Annual Health Care Conference, Mar-05-2013 08:30 AM
Mar 4 13
GnuBIO, Inc. Presents at Cowen and Company, LLC's 33rd Annual Health Care Conference, Mar-05-2013 08:30 AM. Venue: The Boston Marriott Copley Place, Boston, Massachusetts, United States. Speakers: John J. Boyce, Co-Founder, Chief Executive Officer and President.
GnuBIO, Inc. to Unveil the Prototype Fully Integrated DNA Sequencer at the Association of Molecular Pathology Conference
Oct 24 12
GnuBIO, Inc. announced that it will unveil the prototype of the fully integrated DNA sequencer (the K-cup coffee cartridge model of DNA sequencing) at the Association of Molecular Pathology (AMP) conference, booth #330, from October 25(th) -- October 27(th) . The prototype system that the company will unveil at AMP has the exact dimensions and configurations of both the beta and commercial system that will be launched shortly. The prototype is built around optics, electronics and process controls that are installed within the systems running in house. The GnuBIO system has a completely integrated workflow, inclusive of genomic selection, amplification, sequencing and real time informatics (assembly and variant calling), allowing researchers and clinicians to simply inject genomic DNA, and walk away -- with data provided on the targeted regions within a few hours.
Gnubio, Inc. Promotes Susie Truong Harborth as Chief Financial Officer
Oct 18 12
GnuBIO, Inc. announced that Susie Truong Harborth has been promoted to Chief Financial Officer. Ms. Harborth has been with GnuBIO since the company's inception and will continue to lead finance, human resources and operations of the company while taking on new responsibilities for company strategy.
Similar Private Companies By Industry
Recent Private Companies Transactions
April 10, 2014